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it is now approximately ten years since our first reports on a
method of sensitizing guinea pigs to neoarsphenamine. We now
again collaborate on this problem and some of its ramifications,
and here submit the results of our most recent investigations.
Frei (1) produced skin sensitivity to neoarsphenamine (Hoechst) in guinea
pigs by a single intracutaneous injection (1928). No anaphylactic shock was
observed in these animals after intracardial reinjection. Attempts to sensitize
other animals such as monkeys, dogs and rabbits gave negative or no definite
results. Sulzberger (2, 3, 4), working in the same clinic, stated that the sensi-
tivity to neoarsphenamine (Hoechst) can be induced and demonstrated only in
the skin and not in other organs. This skin sensitization could be inhibited if
an intracardial injection was given 24 hours after the intracutaneous prepara-
tion; but desensitization could not be induced by such an intracardial injection
when given after the hypersensitivity had developed. Sulzberger and R. L.
Mayer (5, 6) found that geographic factors influenced sensitization. That is,
they had the best results in Breslau, medium results in ZUrich and negative
results in New York using the same technic and the same brand of neoarsphen-
amine in all three places. Later, they showed that the sensitization could be
induced in ZUrich even when the New York breed of animals was taken from New
York to Europe. One of the factors responsible for these differences was the diet
of the animals, in that green fodder inhibited and dry fodder favored sensitization.
Sulzberger and Oser (7) observed that the amount of vitamine C in the diet had
some definite influence on sensitization, large doses having an inhibitory effect.
(This was the first published study illustrating the immunobiologic effects of
high doses of cevitamic acid.) Sulzberger and Simon (8) found differences in
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the incidence and degree of sensitivity in New York as contrasted with Boston.
Included in their work were findings of George M. Williamson and Morrell show-
ing that the degree of hypersensitiveness depends also upon the brand of the
neoarsphenamine employed. Sulzberger and Simon proved that the guinea pigs
sensitized to neoarsphenamine are in general specifically sensitive to the arseno-
benzol complex and not to other trivalent or to pentavalent organic and inorganic
arsenicals. Frei (9), working on guinea pig nurselings, investigated the question
of why infants do not acquire neoarsphenamine exanthemata. Animals one week
old showed absolute resistance to sensitization; a resistance which gradually dis-
appeared as the animals grew older.
Frei and Sulzberger's findings have been confirmed, for example by Kaplun
and Moreinis (10); Kapuciñki (11); Mu (12); Sbzary, Chwatt and Levy (13).
According to R. L. Mayer (14) guinea pigs sensitized by neoarsphenamine
(Hoechst) were more sensitive to neosilver-arsphenamine and sodium-arsphen-
amine than to neoarsphenamine itself; according to Streitmann and Wied-
mann (15), neoarsphenamine (Hoechst) or the analagous French preparations
gave a higher percentage of sensitivity than solusalvarsan or myosalvarsan.
Cormia had varying results with different groups of guinea pigs (16) and with
different lots of the same brand of neoarsphenamine (17). Chapman and Morrell
(18); Cormia (19) and Streitmann and Wiedmann discussed the influence of the
vitamine C content of the fodder on the development of hypersensitiveness and
in general confirmed the findings of Sulzberger and Oser (7). Mayer; Kallós and
Kallós-Deffner (20); and Cormia (21) obtained different results with the Schultz-
Dale test on the isolated uterus.
A most important contribution in recent years is embodied in the work of
Landsteiner and Jacobs (22) with old arsphenamine. These investigators ob-
tained, after an intracutaneous injection of a dilute un-neutralized solution, a
high degree of skin hypersensitiveness in practically all injected animals. When
such sensitized animals were given a neutralized old arsphenamine solution intra-
venously, a considerable percentage died in typical anaphylactic shock. Al-
though shock occurred even when the solution of the simple chemical was injected,
the reactions were more regular and severe when this solution was mixed with
guinea pig serum. These experiments are of the most far reaching significance
for they demonstrate that old arsphenamine—a simple compound—a non-pro-
tein—is capable both of producing skin hypersensitivity and of producing
anaphylaxis and of eliciting anaphylactic shock. Moreover, the method used by
these authors has the advantage of giving very regular and definite results.
In view of these important findings with old arsphenamine and
since we never had observed anaphylactic shock in our former
experiments with neoarsphenamine, we resumed our studies on
the question of the relationship between skin-sensitiveness and
anaphylaxis.
For these experiments old arsphenamine Hoechst, neoarsphen-
amine Abbott and—f or some complementary examinations—
neoarsphenamine Hoechst were used. In all instances where
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injections were made into the blood stream, the solutions were
mixed with guinea pig serum.
At first we tried to sensitize guinea pigs by intracutaneous
injections of neoarsphenamine Abbott, but obtained the same
negative results as Sulzberger, and Landsteiner and Jacobs in
some of their former experiments working in New York with
other brands of neoarsphenamine.
In contrast to these negative results, intracutaneous injections
of small amounts of un-neutralized old arsphenamine produced
strong skin hypersensitiveness in all of the treated animals,
demonstrable through a second intracutaneous injection. When
these sensitized animals were injected intracardially with neu-
tralized old arsphenamine only a few of them showed signs of
anaphylaxis. Therefore, the intracardial method was abandoned
for the intravenous route used by Landsteiner and Jacobs. With
these intravenous injections, a high percentage of anaphylactic
death was obtained in the same sensitized animals with the same
quantity of arsphenamine. (The question of why the injection
into the jugular vein was more effective than the injection into
the heart will not be discussed in detail here. The color of the
blood aspirated indicated that our intracardial injections were
made into the left heart in about 20 per cent of the animals;
that means into the arterial and not the venous system, but this
20 per cent cannot explain the entire difference.)
Some of the guinea pigs prepared with old arsphenamine were
reinjected intracutaneously with neoarsphenamine Abbott instead
of with old arsphenamine. The skin reactions were strong; there
was only a little less infiltration than elicited by intracutaneous
old-arsphenamine injections. When these animals were injected
intracardially with the same neoarsphenamine, no signs of ana-
phylaxis were seen. These animals as well as unprepared con-
trols showed only some unspecific toxic disturbances. To avoid
such disturbances in the following intravenous injections, smaller
amounts of neoarsphenamine were taken. Also under these con-
ditions, no anaphylactic symptoms were observed. (For details
see following Protocol I.)
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Protocol I. This and the following experiment were carried on during the
winter month8 of 1937—1938 on white, female, non-pregnant guinea pigs weighing
from 200—350 grams and fed a usual adequate diet.
Twenty guinea pigs were injected intracutaneously with 0.15 mg. un-neutral-
ized old arsphenamine Hoechst in 0.1 cc. physiologic saline. After 1—2 days they
showed 3-6 mm., pale-pink erythema or tiny papules, which almost entirely dis-
appeared within a day.
A "flare-up" of the original injection sites was seen in 17 of the animals a few
days later.
Four weeks after the first injection, 12 of these animals were tested intra-
cutaneously with the same amount of old arsphenamine and 7 others with 0.15
mg. of neoarsphenamine Abbott. The old-arsphenamine animals showed in-
flammatory papular reactions of from 6—20 mm. in diameter, some with central
necrosis. The neoarsphenamine animals reacted with lesions of the same size
but with a little less infiltration.
Three weeks later 11 of the animals previously treated with 2 intracutaneous
injections of old arsphenamine and 5 unprepared controls were injected intra-
cardially with a mixture of old arsphenamine plus guinea pig serum. Each ani-
mal received 10 mg. of the drug in 01 cc. saline and 0.09 cc. N/i NaOH made up
to 1.0 cc. with normal guinea-pig serum (see Landsteiner and Jacobs, p. 719).
Of the 11 sensitized animals, one died in typical anaphylaxis (lungs inflated
and heart beating); 4 showed mild anaphylactic symptoms (slight cramps or
cough) and the remaining animals no anaphylactic sign. Of the controls one
died after 18 hours without having an anaphylactic history and the others showed
no signs of shock.
The drop in temperature was, on the whole, greater in the sensitized animals
(average 1.8°C. in sensitized animals and 0.9° in control guinea pigs.)
Again after 3 weeks, the animals injected intracardially with 10 mg. old ar-
sphenamine, were given an intravenous injection of the same amount of old
arsphenamine into the jugular vein.
Five of the 8 guinea pigs tested died in typical anaphylactic shock within 4—7
minutes; 2 showed slight signs of anaphylaxis, while 1 showed no signs of shock.
Of 8 controls, only one showed slight symptoms.
The average drop of temperature in the 3 surviving sensitized animals was
2.6° and in the 8 controls 0.5°.
Six animals previously treated with one intracutaneous injection of old ar-
sphenamine and an intracutaneous injection of neoarsphenamine Abbott, as well
as 5 controls, were injected intracadially with 10 mg. neoarsphenamine Abbott
dissolved in 0.2 cc. saline and made up to 1.0 cc. with normal guinea-pig serum.
All animals, sensitized or not sensitized, showed some toxic disturbances; the
controls rather more so than the sensitized guinea pigs. Both groups had an
average decrease of 1.9° in temperature.
In order to avoid these nonspecific toxic disturbances, different amounts of
neoarsphenamine were tried on normal animals. It was found that 10, 5 and 4
mg. produced disturbances and that 3.75 and 3.5 did not.
Now, the animals formerly tested with 10 mg. neoarsphenamine Abbott intra-
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cardially, received the reduced quantity intravenously. They, like 6 control
animals, did not show any sign of anaphylaxis.
No definite difference was seen in the average drop of temperature of both
groups (0.9° and 0.6°).
Modifying this experiment, another series was started in which
all animals were injected and reinjected intracutaneously with
old arsphenamine. All the guinea pigs showed a strong skin-
hypersensitiveness. The animals were then divided into two
groups: one group was injected intravenously with the above
indicated, reduced amounts of neoarsphenamine Abbott and the
other group with corresponding amounts of old arsphenamine.
All the "old-arsphenamine animals" responded with anaphylactic
symptoms; most of them died in acute shock. The "neoarsphen-
amine animals," however, showed absolutely no signs of anaphy-
laxis. These animals which bad received neoarsphenamine
Abbott intravenously still reacted strongly to an intracutaneous
injection of old arsphenamine. After 3 weeks they were given
another intravenous injection but this time with a suitable
amount of neoarsphenamine Hoechst. The result was the same
as for neoarsphenamine Abbott; that is, no anaphylactic symp-
toms were produced. To convince ourselves that these guinea
pigs were beyond question still susceptible to arsphenamine
anaphylaxis, they were finally injected intravenously with old
arsphenamine. Now, anaphylactic symptoms were seen in all
instances. (For details see following Protocol II.)
Protocol II. Fourteen guinea pigs were sensitized by one intracutaneous in-
jection of 0.15 mg. of old arsphenamine Hoechst. All animals showed a strong
hypersensitiveness to a second intracutaneous injection of the same amount of
drug 4 weeks later.
Then after 3 weeks, 7 of these animals were injected intravenously with old
arsphenamine mixed with guinea pig serum: 5 of them with 3.3 mg. and 2 with
2.0 mg, while 5 controls received 3.3 mg.
Six of the sensitized animals died in typical anaphylactic shock within 31 to
6 minutes and the seventh (3.3 arsphenamine) survived after moderate shock.
The 5 controls showed absolutely no signs of shock.
A second group of 5 of these sensitized animals was intravenously injected with
3.3 mg. of neoarsphenamine Abbott mixed with homologous serum. None
showed any sign of anaphylaxis or even a noticeable drop in temperature, so
that controls were unnecessary.
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Twenty-four hours later these animals were tested intracutaneously with the
usual amount of old arephenamine. They reacted approximately as strongly as
before the intravenous injection.
Therefore, after a lapse of 3 weeks, 4 of the neoarsphenamine animals were
intravenously tested with 5 mg. of neoarsphenamine Hoechst plus serum. This
quantity was chosen after having seen that 10 mg. produced cramps and 5 mg.
did not. None of the sensitized animals showed anaphylactic symptoms and
the drop in temperature was less than in the controls (0.6° and 2.0°).
About 2 weeks later those animals that had received the two brands of neo-
arsphenamine intravenously were given old arsphenamine Hoechst plus serum,
intravenously: 2 received 3.3 mg. and 2 received 5 mg. One animal died within
50 minutes after severe anaphylactic symptoms (5 mg.) and the others survived
after moderate cramps. Five controls (2 given 5 mg. and 3 given 3.3 mg.) did
not show arty reaction. The drop in temperature was about the same in both
groups (1.2° and 1.9°).
In a final experiment a few animals were sensitized with an
intracutaneous injection of un-neutralized old arsphenamine.
When reinjected intracutaneously with the 3 different drugs after
a period of 4 weeks, they showed the same skin hypersensitiveness
to neoarsphenamine Hoechst as to neoarsphenamine Abbott and
to old arsphenamine.
CONCLUSIONS
Guinea pigs regularly acquired strong skin hypersensitiveness
to old arsphenamine after intracutaneous injections of the drug.
When such sensitized animals were reinjected intracarclially
with old arsphenamine plus homologous serum, symptoms of
anaphylaxis were seen only in a few instances. But when these
reinjections were made intravenously, very severe anaphylactic
symptoms were generally observed.
Guinea pigs sensitized to old arsphenamine also gave strong
skin reactions to neoarsphenamine Abbott, but did not respond
with anaphylactic symptoms to intravenous injections of this drug
mixed with homologous serum. The same negative results were
obtained with intravenous injections of neoarsphenamine Hoechst.
From these results it may be concluded that under the condi-
tions of our experiments, old arsphenamine regularly produces a
cutaneous sensitivity to itself as well as to neoarsphenamine Abbott
and Hoechst. Moreover, intracutaneous injection of old arsphen-
amine generally produces anaphylactic sensitivity to old arsphen-
amine but not to the neoarsphenamines.
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